Analysts’ View: Carvana (CVNA), Tapestry (TPR), Diplomat Pharmacy (DPLO)

Brokerage Firm B. Riley FBR, Inc. upgraded Carvana Co. (NYSE:CVNA) shares from Sell to Buy rating while increasing their price target from $20 to $38.

Carvana Co., together with its subsidiaries, operates an e-commerce platform for buying used cars in the United States.


Investment Analysts at BofA/Merrill upgraded Tapestry, Inc. (NYSE:TPR) shares from Neutral to Buy rating.

Tapestry, Inc. provides luxury accessories and lifestyle brands.


Diplomat Pharmacy, Inc. (NYSE:DPLO) shares were upgraded by analysts at JP Morgan from Neutral to Overweight rating.

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at